Vicarious Surgical (NYSE:RBOT) Earns “Neutral” Rating from BTIG Research

Vicarious Surgical (NYSE:RBOT)‘s stock had its “neutral” rating reiterated by equities researchers at BTIG Research in a note issued to investors on Friday,Benzinga reports.

A number of other research firms have also commented on RBOT. Weiss Ratings restated a “sell (e+)” rating on shares of Vicarious Surgical in a research report on Wednesday, October 8th. Wall Street Zen raised Vicarious Surgical to a “sell” rating in a research note on Saturday, September 13th. Two equities research analysts have rated the stock with a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the company has an average rating of “Reduce” and an average price target of $7.00.

Vicarious Surgical Stock Performance

Shares of RBOT stock opened at $2.59 on Friday. The firm has a market cap of $16.96 million, a price-to-earnings ratio of -0.29 and a beta of 1.51. Vicarious Surgical has a 52 week low of $2.44 and a 52 week high of $18.97. The firm’s 50-day simple moving average is $4.39 and its two-hundred day simple moving average is $6.49.

Vicarious Surgical (NYSE:RBOT) last posted its quarterly earnings results on Wednesday, November 12th. The company reported ($1.91) earnings per share for the quarter, topping the consensus estimate of ($2.37) by $0.46. Analysts forecast that Vicarious Surgical will post -10.89 earnings per share for the current year.

Hedge Funds Weigh In On Vicarious Surgical

Institutional investors have recently modified their holdings of the company. Connective Capital Management LLC purchased a new position in shares of Vicarious Surgical during the 3rd quarter valued at about $169,000. DNB Asset Management AS grew its position in Vicarious Surgical by 12.1% during the second quarter. DNB Asset Management AS now owns 29,199 shares of the company’s stock valued at $219,000 after acquiring an additional 3,154 shares during the last quarter. Finally, Dimensional Fund Advisors LP raised its stake in shares of Vicarious Surgical by 22.1% during the third quarter. Dimensional Fund Advisors LP now owns 19,975 shares of the company’s stock worth $110,000 after acquiring an additional 3,615 shares in the last quarter. 47.27% of the stock is currently owned by institutional investors.

Vicarious Surgical Company Profile

Vicarious Surgical Inc operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc was incorporated in 2014 and is headquartered in Waltham, Massachusetts.